Endocardial repolarization dispersion in BrS: A novel automatic algorithm for mapping activation recovery interval.

Brugada syndrome Tpeak-Tend interval activation recovery interval electroanatomic substrate endocardial mapping repolarization dispersion

Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
13 Mar 2024
Historique:
revised: 20 02 2024
received: 03 12 2023
accepted: 27 02 2024
medline: 13 3 2024
pubmed: 13 3 2024
entrez: 13 3 2024
Statut: aheadofprint

Résumé

Repolarization dispersion in the right ventricular outflow tract (RVOT) contributes to the type-1 electrocardiographic (ECG) phenotype of Brugada syndrome (BrS), while data on the significance and feasibility of mapping repolarization dispersion in BrS patients are scarce. Moreover, the role of endocardial repolarization dispersion in BrS is poorly investigated. We aimed to assess endocardial repolarization patterns through an automated calculation of activation recovery interval (ARI) estimated on unipolar electrograms (UEGs) in spontaneous type-1 BrS patients and controls; we also investigated the relation between ARI and right ventricle activation time (RVAT), and T-wave peak-to-end interval (Tpe) in BrS patients. Patients underwent endocardial high-density electroanatomical mapping (HDEAM); BrS showing an overt type-1 ECG were defined as OType1, while those without (latent type-1 ECG and LType1) received ajmaline infusion. BrS patients only underwent programmed ventricular stimulation (PVS). Data were elaborated to obtain ARI corrected with the Bazett formula (ARIc), while RVAT was derived from activation maps. 39 BrS subjects (24 OType1 and 15 LTtype1) and 4 controls were enrolled. OType1 and post-ajmaline LType1 showed longer mean ARIc than controls (306 ± 27.3 ms and 333.3 ± 16.3 ms vs. 281.7 ± 10.3 ms, p = .05 and p < .001, respectively). Ajmaline induced a significant prolongation of ARIc compared to pre-ajmaline LTtype1 (333.3 ± 16.3 vs. 303.4 ± 20.7 ms, p < .001) and OType1 (306 ± 27.3 ms, p < .001). In patients with type-1 ECG (OTtype1 and post-ajmaline LType1) ARIc correlated with RVAT (r = .34, p = .04) and Tpec (r = .60, p < .001), especially in OType1 subjects (r = .55, p = .008 and r = .65 p < .001, respectively). ARIc mapping demonstrates increased endocardial repolarization dispersion in RVOT in BrS. Endocardial ARIc positively correlates with RVAT and Tpec, especially in OType1.

Identifiants

pubmed: 38477371
doi: 10.1111/jce.16244
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 Wiley Periodicals LLC.

Références

Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol. 1992;20:1391-1396.
Meregalli P, Wilde A, Tan H. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? Cardiovasc Res. 2005;67:367-378.
Tukkie R, Sogaard P, Vleugels J, de Groot IKLM, Wilde AAM, Tan HL. Delay in right ventricular activation contributes to Brugada syndrome. Circulation. 2004;109:1272-1277.
Emori T, Antzelevitch C. Cellular basis for complex T waves and arrhythmic activity following combined IKr and IKs block. J Cardiovasc Electrophysiol. 2001;12:1369-1378.
Tse G, Gong M, Li CKH, et al. Tpeak-Tend, Tpeak-Tend/QT ratio and Tpeak-Tend dispersion for risk stratification in Brugada syndrome: a systematic review and meta-analysis. J Arrhythm. 2018;34:587-597.
Wyatt RF, Burgess MJ, Evans AK, Lux RL, Abildskov JA, Tsutsumi T. Estimation of ventricular transmembrane action potential durations and repolarization times from unipolar electrograms. Am J Cardiol. 1981;47:488.
Pannone L, Monaco C, Ramak R, et al. New insights into risk stratification of Brugada syndrome from high density epicardial electroanatomic mapping. Eur Heart J. 2021;42:638.
Zhang P, Tung R, Zhang Z, et al. Characterization of the epicardial substrate for catheter ablation of Brugada syndrome. Heart Rhythm. 2016;13:2151-2158.
Nagase S, Kusano KF, Morita H, et al. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome. J Am Coll Cardiol. 2008;51:1154-1161.
Lambiase PD, Ahmed AK, Ciaccio EJ, et al. High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis. Circulation. 2009;120:106-117.
Leong KMW, Ng FS, Yao C, et al. ST-elevation magnitude correlates with right ventricular outflow tract conduction delay in Type I Brugada ECG. Circ Arrhythm Electrophysiol. 2017;10:e005107.
Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10:1932-1963.
Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43:3997-4126.
Sroubek J, Probst V, Mazzanti A, et al. Programmed ventricular stimulation for risk stratification in the Brugada syndrome. Circulation. 2016;133:622-630.
Letsas KP, Efremidis M, Vlachos K, et al. Right ventricular outflow tract low-voltage areas identify the site of origin of idiopathic ventricular arrhythmias: A high-density mapping study. J Cardiovasc Electrophysiol. 2019;30:2362-2369.
Williams SE, Roney CH, Connolly A, et al. OpenEP: a cross-platform electroanatomic mapping data format and analysis platform for electrophysiology research. Front Physiol. 2021;12:160.
Ahrens J, Geveci B, Law C. ParaView: an end-user tool for large data visualization. The Visualization Handbook, 2005.
Antzelevitch C, Di Diego JM. Tpeak-Tend interval as a marker of arrhythmic risk. Heart Rhythm. 2019;16:954-955.
Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation. 1999;100:1660-1666.
Coronel R, de Bakker JMT, Wilms-Schopman FJG, et al. Monophasic action potentials and activation recovery intervals as measures of ventricular action potential duration: experimental evidence to resolve some controversies. Heart Rhythm. 2006;3:1043-1050.
Martin CA, Guzadhur L, Grace AA, Lei M, Huang CLH. Mapping of reentrant spontaneous polymorphic ventricular tachycardia in a Scn5a+/- mouse model. Am J Physiol Heart Circ Physiol. 2011;300:H1853-H1862.
Nademanee K, Veerakul G, Chandanamattha P, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011;123:1270-1279.
Szél T, Antzelevitch C. Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome. J Am Coll Cardiol. 2014;63:2037-2045.
Antzelevitch C, Patocskai B. Ajmaline-induced slowing of conduction in the right ventricular outflow tract cannot account for ST elevation in patients with type I Brugada ECG. Circ Arrhythm Electrophysiol. 2017;10:e005775.
Maury P, Sacher F, Gourraud JB, et al. Increased Tpeak-Tend interval is highly and independently related to arrhythmic events in Brugada syndrome. Heart Rhythm. 2015;12:2469-2476.
Priori SG, Gasparini M, Napolitano C, et al. Risk stratification in Brugada syndrome. J Am Coll Cardiol. 2012;59:37-45.

Auteurs

Sara Latrofa (S)

Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy.

Valentina Hartwig (V)

Institute of Clinical Physiology, Pisa, Italy.

Lorenzo Bachi (L)

Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy.

Pasquale Notarstefano (P)

Cardiovascular and Neurological Department, San Donato Hospital, Arezzo, Italy.

Silvia Garibaldi (S)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Luca Panchetti (L)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Martina Nesti (M)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Paolo Seghetti (P)

Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy.
Institute of Clinical Physiology, Pisa, Italy.

Umberto Startari (U)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Gianluca Mirizzi (G)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Maria Sole Morelli (MS)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Martina Modena (M)

Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy.

Andrea Mazzanti (A)

Department of Molecular Medicine, University of Pavia, Pavia, Italy.

Michele Emdin (M)

Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy.
Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Alberto Giannoni (A)

Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy.
Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Andrea Rossi (A)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Classifications MeSH